Serine/threonine protein kinase 3D structures
From Proteopedia
(Difference between revisions)
(15 intermediate revisions not shown.) | |||
Line 11: | Line 11: | ||
**[[1nvq]], [[1nvr]] – hChk1 kinase domain + peptide + saurosporine | **[[1nvq]], [[1nvr]] – hChk1 kinase domain + peptide + saurosporine | ||
- | **[[1nvs]], [[1zys]] - hChk1 kinase domain + peptide + inhibitor | + | **[[1nvs]], [[1zys]], [[7ako]] - hChk1 kinase domain + peptide + inhibitor |
- | **[[2cgu]], [[2cgv]], [[2cgw]], [[2cgx]], [[2c3j]], [[2c3k]], [[2c3l]], [[2br1]], [[2brb]], [[2brg]], [[2brh]], [[2brm]], [[2brn]], [[2bro]], [[2ayp]], [[2gdo]], [[2ghg]], [[2hog]], [[2ywp]], [[2hxl]], [[2hxq]], [[2hy0]], [[2r0u]], [[2e9n]], [[2e9o]], [[2e9p]], [[2e9u]], [[2e9v]], [[2qhm]], [[2qhn]], [[3f9n]], [[2wmq]], [[2wmr]], [[2wms]], [[2wmt]], [[2wmu]], [[2wmv]], [[2wmx]], [[3jvr]], [[3jvs]], [[2xey]], [[2xf0]], [[2xez]], [[2x8d]], [[2x8e]], [[2x8i]], [[3ot3]], [[3ot8]], [[3pa3]], [[3pa4]], [[3pa5]], [[3nlb]], [[2wmw]], [[2ydi]], [[2ydj]], [[2ydk]], [[2yer]], [[2yex]], [[2ym3]], [[2ym4]], [[2ym5]], [[2ym6]], [[2ym7]], [[2ym8]], [[3tkh]], [[3tki]], [[3u9n]], [[4fsm]], [[4fsn]], [[4fsq]], [[4fsr]], [[4fst]], [[4fsu]], [[4fsw]], [[4fsy]], [[4fsz]], [[4ft0]], [[4ft3]], [[4ft5]], [[4ft7]], [[4ft9]], [[4fta]], [[4ftc]], [[4fti]], [[4ftj]], [[4ftk]], [[4ftl]], [[4ftm]], [[4ftn]], [[4fto]], [[4ftq]], [[4ftr]], [[4ftt]], [[4ftu]], [[4gh2]], [[4hyh]], [[4hyi]], [[4jik]], [[4rvm]], [[4rvl]], [[4rvk]], [[4qyh]], [[4qyg]], [[4qyf]], [[4qye]], [[5dls]], [[5f4n]], [[6fc8]], [[5fcf]], [[5fck]], [[6fck]], [[6fcf]] - hChk1 kinase domain + inhibitor<br /> | + | **[[7akm]] - hChk1 kinase domain + ATP<br /> |
- | **[[5oot]], [[5op2]], [[5op4]], [[5op5]], [[5op7]], [[5opb]], [[5opr]], [[5ops]], [[5opu]], [[5opv]], [[5oq5]], [[5oq6]], [[5oq7]], [[5oq8]] | + | **[[2cgu]], [[2cgv]], [[2cgw]], [[2cgx]], [[2c3j]], [[2c3k]], [[2c3l]], [[2br1]], [[2brb]], [[2brg]], [[2brh]], [[2brm]], [[2brn]], [[2bro]], [[2ayp]], [[2gdo]], [[2ghg]], [[2hog]], [[2ywp]], [[2hxl]], [[2hxq]], [[2hy0]], [[2r0u]], [[2e9n]], [[2e9o]], [[2e9p]], [[2e9u]], [[2e9v]], [[2qhm]], [[2qhn]], [[3f9n]], [[2wmq]], [[2wmr]], [[2wms]], [[2wmt]], [[2wmu]], [[2wmv]], [[2wmx]], [[3jvr]], [[3jvs]], [[2xey]], [[2xf0]], [[2xez]], [[2x8d]], [[2x8e]], [[2x8i]], [[3ot3]], [[3ot8]], [[3pa3]], [[3pa4]], [[3pa5]], [[3nlb]], [[2wmw]], [[2ydi]], [[2ydj]], [[2ydk]], [[2yer]], [[2yex]], [[2ym3]], [[2ym4]], [[2ym5]], [[2ym6]], [[2ym7]], [[2ym8]], [[3tkh]], [[3tki]], [[3u9n]], [[4fsm]], [[4fsn]], [[4fsq]], [[4fsr]], [[4fst]], [[4fsu]], [[4fsw]], [[4fsy]], [[4fsz]], [[4ft0]], [[4ft3]], [[4ft5]], [[4ft7]], [[4ft9]], [[4fta]], [[4ftc]], [[4fti]], [[4ftj]], [[4ftk]], [[4ftl]], [[4ftm]], [[4ftn]], [[4fto]], [[4ftq]], [[4ftr]], [[4ftt]], [[4ftu]], [[4gh2]], [[4hyh]], [[4hyi]], [[4jik]], [[4rvm]], [[4rvl]], [[4rvk]], [[4qyh]], [[4qyg]], [[4qyf]], [[4qye]], [[5dls]], [[5f4n]], [[6fc8]], [[5fcf]], [[5fck]], [[6fck]], [[6fcf]], [[7bko]], [[8e80]]. ]]8o81]] - hChk1 kinase domain + inhibitor<br /> |
+ | **[[5oot]], [[5op2]], [[5op4]], [[5op5]], [[5op7]], [[5opb]], [[5opr]], [[5ops]], [[5opu]], [[5opv]], [[5oq5]], [[5oq6]], [[5oq7]], [[5oq8]], [[7bjd]], [[7bjh]], [[7bjj]], [[7bjm]], [[7bjo]], [[7bjr]], [[7bjx]], [[7bk1]], [[7bk2]], [[7bk3]], [[7mck]], [[7suf]], [[7sug]], [[7suh]], [[7sui]], [[7suj]], [[8siv]], [[8siw]], [[8six]] - hChk1 kinase domain (mutant) + inhibitor<br /> | ||
**[[5oop]] - hChk1 kinase domain (mutant) + AMPPNP<br /> | **[[5oop]] - hChk1 kinase domain (mutant) + AMPPNP<br /> | ||
**[[5oor]] - hChk1 kinase domain (mutant) + staurosporine<br /> | **[[5oor]] - hChk1 kinase domain (mutant) + staurosporine<br /> | ||
+ | **[[7bkn]] - hChk1 kinase domain + adenine<br /> | ||
+ | **[[7bje]] - hChk1 kinase domain (mutant) + adenine<br /> | ||
**[[2jqi]] – yChk1 – yeast<br /> | **[[2jqi]] – yChk1 – yeast<br /> | ||
Line 37: | Line 40: | ||
**[[4lgd]] – hChk3 kinase domain + RASSF5 SARAH domain<br /> | **[[4lgd]] – hChk3 kinase domain + RASSF5 SARAH domain<br /> | ||
**[[6ao5]] – hChk3 kinase+SARAH domains (mutant) + SAV1 SARAH domain<br /> | **[[6ao5]] – hChk3 kinase+SARAH domains (mutant) + SAV1 SARAH domain<br /> | ||
- | **[[5dh3]] – hChk3 kinase domain + inhibitor<br /> | + | **[[5dh3]], [[8a66]] – hChk3 kinase domain + inhibitor<br /> |
- | *'''Chk4 (Mst1)''' | + | *'''Chk4 (Mst1)''' ); Domains – kinase 1-311; SARAH 432-480 |
- | **[[2jo8]] – hChk4 C terminal domain - NMR<br /> | ||
**[[3com]] – hChk4 kinase domain<br /> | **[[3com]] – hChk4 kinase domain<br /> | ||
+ | **[[6yat]], [[8a5j]] – hChk4 kinase domain + inhibitor<br /> | ||
**[[4nr2]] – hChk4 SARAH domain<br /> | **[[4nr2]] – hChk4 SARAH domain<br /> | ||
+ | **[[2jo8]] – hChk4 SARAH domain - NMR<br /> | ||
**[[4oh8]] – hChk4 SARAH domain + Ras association domain-containing protein<br /> | **[[4oh8]] – hChk4 SARAH domain + Ras association domain-containing protein<br /> | ||
Line 63: | Line 67: | ||
**[[6cpf]] – hChk6 kinase domain + AMPPCP<br /> | **[[6cpf]] – hChk6 kinase domain + AMPPCP<br /> | ||
**[[5g15]] – hChk6 kinase domain + AMPPNP + monobody<br /> | **[[5g15]] – hChk6 kinase domain + AMPPNP + monobody<br /> | ||
- | **[[6cpg]] – hChk6 kinase domain + inhibitor + monobody<br /> | + | **[[6cpg]], [[8ssp]] – hChk6 kinase domain + inhibitor + monobody<br /> |
- | **[[2j4z]], [[2j50]], [[2np8]], [[3efw]], [[2x81]], [[2x6d]], [[2x6e]], [[3myg]], [[3vap]], [[4b0g]], [[4j8m]], [[5dpv]], [[5dr6]], [[5dr9]], [[5dt0]], [[5ew9]], [[5one]], [[5obr]], [[4byi]], [[4byj]], [[4jai]], [[4jaj]], [[3w10]], [[3w16]], [[3w18]], [[3w2c]], [[4uzh]], [[4uzd]], [[4uyn]], [[4zs0]], [[4ztq]], [[4ztr]], [[4zts]], [[5aad]], [[5aae]], [[5aag]], [[5dr6]], [[5dr9]], [[5dt0]], [[5ew9]], [[5obr]], [[5one]], [[6gra]], [[6c2t]], [[6c2r]], [[5zan]] – hChk6 kinase domain + inhibitor<br /> | + | **[[2j4z]], [[2j50]], [[2np8]], [[3efw]], [[2x81]], [[2x6d]], [[2x6e]], [[3myg]], [[3vap]], [[4b0g]], [[4j8m]], [[5dpv]], [[5dr6]], [[5dr9]], [[5dt0]], [[5ew9]], [[5one]], [[5obr]], [[4byi]], [[4byj]], [[4jai]], [[4jaj]], [[3w10]], [[3w16]], [[3w18]], [[3w2c]], [[4uzh]], [[4uzd]], [[4uyn]], [[4zs0]], [[4ztq]], [[4ztr]], [[4zts]], [[5aad]], [[5aae]], [[5aag]], [[5dr6]], [[5dr9]], [[5dt0]], [[5ew9]], [[5obr]], [[5one]], [[6gra]], [[6c2t]], [[6c2r]], [[5zan]], [[6z4y]], [[7ayh]], [[7ayi]], [[7fic]], [[7o2v]], [[8jmx]] – hChk6 kinase domain + inhibitor<br /> |
**[[2bmc]], [[2c6e]], [[3coh]], [[3h0y]], [[3h0z]], [[3h10]], [[3fdn]], [[2wtw]], [[3lau]], [[3nrm]], [[2xne]], [[2xng]], [[2xru]], [[3k5u]], [[3m11]], [[3p9j]], [[3r21]], [[3r22]], [[3qbn]], [[3unz]], [[3uo4]], [[3uo5]], [[3uo6]], [[3uod]], [[3uoh]], [[3uoj]], [[3uok]], [[3uol]], [[3up2]], [[3up7]], [[4dhf]], [[4dea]], [[4deb]], [[4ded]], [[4dee]], [[5aad]], [[5aae]], [[5aaf]], [[5aag]], [[4jbo]], [[4jbp]], [[4jbq]], [[4prj]], [[5dpv]], [[6hjk]], [[6hjj]] – hChk6 kinase domain (mutant) + inhibitor<br /> | **[[2bmc]], [[2c6e]], [[3coh]], [[3h0y]], [[3h0z]], [[3h10]], [[3fdn]], [[2wtw]], [[3lau]], [[3nrm]], [[2xne]], [[2xng]], [[2xru]], [[3k5u]], [[3m11]], [[3p9j]], [[3r21]], [[3r22]], [[3qbn]], [[3unz]], [[3uo4]], [[3uo5]], [[3uo6]], [[3uod]], [[3uoh]], [[3uoj]], [[3uok]], [[3uol]], [[3up2]], [[3up7]], [[4dhf]], [[4dea]], [[4deb]], [[4ded]], [[4dee]], [[5aad]], [[5aae]], [[5aaf]], [[5aag]], [[4jbo]], [[4jbp]], [[4jbq]], [[4prj]], [[5dpv]], [[6hjk]], [[6hjj]] – hChk6 kinase domain (mutant) + inhibitor<br /> | ||
**[[5dt4]], [[5obj]] – hChk6 kinase domain + ATP + inhibitor<br /> | **[[5dt4]], [[5obj]] – hChk6 kinase domain + ATP + inhibitor<br /> | ||
Line 70: | Line 74: | ||
**[[5dn3]], [[5dos]], [[5dt4]], [[5obj]] – hChk6 kinase domain + ATP + inhibitor <br /> | **[[5dn3]], [[5dos]], [[5dt4]], [[5obj]] – hChk6 kinase domain + ATP + inhibitor <br /> | ||
**[[6c83]] – hChk6 kinase domain + AMPPCP + nanobody<br /> | **[[6c83]] – hChk6 kinase domain + AMPPCP + nanobody<br /> | ||
+ | **[[8sso]] – hChk6 kinase domain + drug + monobody<br /> | ||
**[[5dr2]] – hChk6 kinase domain (mutant) + ATP + inhibitor <br /> | **[[5dr2]] – hChk6 kinase domain (mutant) + ATP + inhibitor <br /> | ||
- | **[[5g1x]] – hChk6 kinase domain (mutant) + N-Myc <br /> | + | **[[5g1x]], [[7ztl]] – hChk6 kinase domain (mutant) + N-Myc <br /> |
+ | **[[8guw]] – hChk6 kinase domain/activator peptide <br /> | ||
**[[5l8j]], [[5l8k]], [[5l8l]] – hChk6 kinase domain (mutant) + new antigen receptor variable domain <br /> | **[[5l8j]], [[5l8k]], [[5l8l]] – hChk6 kinase domain (mutant) + new antigen receptor variable domain <br /> | ||
**[[5lxm]] – hChk6 kinase domain (mutant) + Targeting protein for XKLP2 <br /> | **[[5lxm]] – hChk6 kinase domain (mutant) + Targeting protein for XKLP2 <br /> | ||
Line 90: | Line 96: | ||
**[[6r49]] – hChk6 kinase domain (mutant) + PThr + CoA<br /> | **[[6r49]] – hChk6 kinase domain (mutant) + PThr + CoA<br /> | ||
- | *'''Chk10 (lymphocyte-oriented kinase)''' | + | *'''Chk10 (lymphocyte-oriented kinase)''' or LOK or STK10 |
- | **[[2j7t]], [[4aot]], [[4equ]], [[5ajq]], [[5owq]], [[5owr]], [[6eim]], [[6gtt]], [[6i2y]], [[6hxf]] – hChk10 kinase domain + inhibitor<br /> | + | **[[7qgp]] – hChk10 <br /> |
+ | **[[2j7t]], [[4aot]], [[4equ]], [[4usd]], [[4use]], [[5ajq]], [[5owq]], [[5owr]], [[6eim]], [[6gtt]], [[6i2y]], [[6hxf]] – hChk10 kinase domain + inhibitor<br /> | ||
+ | **[[4bc6]], [[6i2y]] – hChk10 + drug <br /> | ||
*'''Chk11''' | *'''Chk11''' | ||
Line 106: | Line 114: | ||
*'''Chk13 (Polo-like kinase Plk)''' | *'''Chk13 (Polo-like kinase Plk)''' | ||
- | *Plk1 Polo-box domain (Pbd)'' | + | *Plk1 Polo-box domain (Pbd) 371-594'' |
**[[1q4o]], [[2ogq]], [[3hih]], [[3p2w]], [[4h5x]], [[6n46]] – hPlk1 Pbd<br /> | **[[1q4o]], [[2ogq]], [[3hih]], [[3p2w]], [[4h5x]], [[6n46]] – hPlk1 Pbd<br /> | ||
+ | **[[8joq]], [[8joy]] – hPlk1 Pbd + hpv peptide<br /> | ||
*Plk1 Pbd complex with polypeptide | *Plk1 Pbd complex with polypeptide | ||
- | **[[1umw]], [[2ojx]], [[3bzi]], [[3c5l]], [[3rq7]], [[4dfw]], [[4whl]], [[4whk]], [[4whh]], [[4rcp]], [[4o6w]], [[4o56]], [[5dms]], [[5dmv]], [[5dnj]] – hPlk1 + peptide<br /> | + | **[[1umw]], [[2ojx]], [[3bzi]], [[3c5l]], [[3rq7]], [[4dfw]], [[4whl]], [[4whk]], [[4whh]], [[4rcp]], [[4o6w]], [[4o56]], [[5dms]], [[5dmv]], [[5dnj]], [[7mso]], [[7mx1]] – hPlk1 + peptide<br /> |
**[[3hik]], [[3fvh]], [[3p2z]], [[3p34]], [[3p35]], [[3p36]], [[3p37]], [[3q1i]], [[4e67]], [[4e9c]], [[4e9d]], [[4hab]], [[4hy2]], [[4o9w]], [[4x9r]], [[4x9v]], [[4x9w]], [[5j19]], [[6gy2]] – hPlk1 + phosphopeptide<br /> | **[[3hik]], [[3fvh]], [[3p2z]], [[3p34]], [[3p35]], [[3p36]], [[3p37]], [[3q1i]], [[4e67]], [[4e9c]], [[4e9d]], [[4hab]], [[4hy2]], [[4o9w]], [[4x9r]], [[4x9v]], [[4x9w]], [[5j19]], [[6gy2]] – hPlk1 + phosphopeptide<br /> | ||
**[[1q4k]] – hPlk1 (mutant) + phosphopeptide<br /> | **[[1q4k]] – hPlk1 (mutant) + phosphopeptide<br /> | ||
Line 120: | Line 129: | ||
**[[6ax4]] – hChk Plk1 + histidine cyclized macrocycle <br /> | **[[6ax4]] – hChk Plk1 + histidine cyclized macrocycle <br /> | ||
**[[5x3s]] – mPlk1 + phosphopeptide<br /> | **[[5x3s]] – mPlk1 + phosphopeptide<br /> | ||
+ | **[[8joq]], [[8joy]] – hPlk1 Pbd + hpv peptide<br /> | ||
*Plk1 Pbd complex with small molecule inhibitor | *Plk1 Pbd complex with small molecule inhibitor | ||
- | **[[4h71]], [[4hco]], [[5ta6]], [[5ta8]] – hPlk1 + inhibitor<br /> | + | **[[4h71]], [[4hco]], [[5ta6]], [[5ta8]], [[8bjt]], [[8crc]] – hPlk1 + inhibitor<br /> |
**[[2rku]] – hPlk1 (mutant) + inhibitor<br /> | **[[2rku]] – hPlk1 (mutant) + inhibitor<br /> | ||
**[[3db6]], [[3db8]], [[3dbc]], [[3dbd]], [[3dbe]], [[3dbf]] – zfPlk1 (mutant) + inhibitor – zebra fish<br /> | **[[3db6]], [[3db8]], [[3dbc]], [[3dbd]], [[3dbe]], [[3dbf]] – zfPlk1 (mutant) + inhibitor – zebra fish<br /> | ||
- | *Plk1 catalytic domain | + | *Plk1 catalytic domain 36-345 |
**[[2owb]] – hPlk1 catalytic domain (mutant)<br /> | **[[2owb]] – hPlk1 catalytic domain (mutant)<br /> | ||
Line 146: | Line 156: | ||
**[[4b6l]], [[4i6b]] – hChk Plk3 kinase domain + inhibitor<br /> | **[[4b6l]], [[4i6b]] – hChk Plk3 kinase domain + inhibitor<br /> | ||
- | *'''Plk4''' | + | *'''Plk4'''; Domains – kinase 2-275; Pbd 580-808; Pb3 884-970 |
**[[3cok]] – hChk Plk4 kinase domain<br /> | **[[3cok]] – hChk Plk4 kinase domain<br /> | ||
**[[4n9j]] – hChk Plk4 Pbd domain<br /> | **[[4n9j]] – hChk Plk4 Pbd domain<br /> | ||
**[[4n7z]], [[4n7v]] – hChk Plk4 Pbd domain + centrosomal protein <br /> | **[[4n7z]], [[4n7v]] – hChk Plk4 Pbd domain + centrosomal protein <br /> | ||
+ | **[[6w38]], [[6w3i]] – hChk Plk4 Pbd domain + Fam46C<br /> | ||
+ | **[[6w3j]] – hChk Plk4 Pbd domain + Fam46C + CEP92 peptide<br /> | ||
**[[4jxf]], [[4yur]] – hChk Plk4 kinase domain + inhibitor<br /> | **[[4jxf]], [[4yur]] – hChk Plk4 kinase domain + inhibitor<br /> | ||
**[[5lhy]] – hChk Plk4 Pb3 domain<br /> | **[[5lhy]] – hChk Plk4 Pb3 domain<br /> | ||
**[[4yyp]], [[5lhz]] – hChk Plk4 Pb3 domain + Scl-interrupting locus protein <br /> | **[[4yyp]], [[5lhz]] – hChk Plk4 Pb3 domain + Scl-interrupting locus protein <br /> | ||
- | **[[4nk7]], [[4g7n]], [[5lhx]] – DmChk Plk4 Pbd domain – ''Drosophila melanogaster''<br /> | + | **[[4nk7]], [[4g7n]], [[5lhx]], [[7rl3]] – DmChk Plk4 Pbd domain – ''Drosophila melanogaster''<br /> |
*'''Chk16''' | *'''Chk16''' | ||
Line 160: | Line 172: | ||
**[[2buj]] – hChk16 (mutant) + staurosporin <br /> | **[[2buj]] – hChk16 (mutant) + staurosporin <br /> | ||
- | *''' | + | *'''Chk17B''' or DRAK2 or STK17B |
**[[3lm0]] – hChk17B <br /> | **[[3lm0]] – hChk17B <br /> | ||
- | **[[6qf4]] – hChk17B + ADP<br /> | + | **[[6qf4]], [[7q7c]], [[7q7d]] – hChk17B + ADP<br /> |
+ | **[[7q7e]] – hChk17B + ATP<br /> | ||
**[[3lm5]] – hChk17B + quercetin<br /> | **[[3lm5]] – hChk17B + quercetin<br /> | ||
+ | **[[6y6f]], [[6y6h]], [[6zjf]] – hChk17B + pyrimidine derivative<br /> | ||
+ | **[[7akg]] – hChk17B + drug<br /> | ||
- | *'''Chk24 (Mst3)''' | + | *'''Chk19''' or STK19 |
+ | |||
+ | **[[7xrb]] – hChk19 <br /> | ||
+ | |||
+ | *'''Chk24 (Mst3)''' or STK24 | ||
**[[3a7f]], [[3a7g]], [[3a7h]], [[3a7i]], [[3a7j]], [[3ckw]] – hChk24 kinase domain <br /> | **[[3a7f]], [[3a7g]], [[3a7h]], [[3a7i]], [[3a7j]], [[3ckw]] – hChk24 kinase domain <br /> | ||
- | **[[4w8e]], [[4w8d]], [[4u8z]], [[4qmm]], [[4qmn]], [[4qmo]], [[4qmp]], [[4qmq]], [[4qms]], [[4qmt]], [[4qmu]], [[4qmv]], [[4qmw]], [[4qmx]], [[4qmy]], [[4qmz]], [[4qna]], [[4qo9]], [[4u8z]] | + | **[[4w8e]], [[4w8d]], [[4u8z]], [[4qmm]], [[4qmn]], [[4qmo]], [[4qmp]], [[4qmq]], [[4qms]], [[4qmt]], [[4qmu]], [[4qmv]], [[4qmw]], [[4qmx]], [[4qmy]], [[4qmz]], [[4qna]], [[4qo9]], [[4u8z]], [[7b30]], [[7b31]], [[7b32]], [[7b33]], [[7b34]], [[7b35]], [[8bzi]], [[8bzj]], [[8qlr]], [[8qls]], [[8qlt]] – hChk Mst3 + inhibitor <br /> |
+ | **[[8qlq]] – hChk Mst3 + macrocyclic inhibitor <br /> or STK2 | ||
**[[3ckx]] – hChk24 kinase domain + staurosporin <br /> | **[[3ckx]] – hChk24 kinase domain + staurosporin <br /> | ||
**[[3zhp]] – hChk24 kinase domain + calcium-binding protein <br /> | **[[3zhp]] – hChk24 kinase domain + calcium-binding protein <br /> | ||
Line 175: | Line 195: | ||
**[[4qml]] – hChk Mst3 kinase domain + AMPPNP <br /> | **[[4qml]] – hChk Mst3 kinase domain + AMPPNP <br /> | ||
- | *'''Chk25''' | + | *'''Chk25 or STK25''' |
**[[2xik]] – hChk25 kinase domain<br /> | **[[2xik]] – hChk25 kinase domain<br /> | ||
+ | **[[7z4v]] – hChk25 kinase domain + inhibitor<br /> | ||
**[[3w8h]] – hChk25 regulatory domain + programmed cell death protein 10<br /> | **[[3w8h]] – hChk25 regulatory domain + programmed cell death protein 10<br /> | ||
**[[4nzw]] – hChk25 kinase domain (mutant) + calcium-binding protein <br /> | **[[4nzw]] – hChk25 kinase domain (mutant) + calcium-binding protein <br /> | ||
Line 183: | Line 204: | ||
*'''Chk26 (Mst4)''' | *'''Chk26 (Mst4)''' | ||
- | **[[3ggf]] – hChk Mst4 + inhibitor <br /> | + | **[[3ggf]], [[7b36]] – hChk Mst4 + inhibitor <br /> |
**[[4geh]], [[3w8i]] - hChk Mst4 dimerization domain + programmed cell death protein 10<br /> | **[[4geh]], [[3w8i]] - hChk Mst4 dimerization domain + programmed cell death protein 10<br /> | ||
**[[4fza]], [[4fzd]], [[4fzf]] – hChk Mst4 (mutant) + calcium-binding protein <br /> | **[[4fza]], [[4fzd]], [[4fzf]] – hChk Mst4 (mutant) + calcium-binding protein <br /> | ||
Line 197: | Line 218: | ||
*'''Chk39''' or SPAK | *'''Chk39''' or SPAK | ||
+ | **[[7o86]] – hChk39 C-terminal<br /> | ||
**[[5d9h]] – mChk39 residues 63-403 + ATP<br /> | **[[5d9h]] – mChk39 residues 63-403 + ATP<br /> | ||
**[[5dbx]] – mChk39 residues 63-403 (mutant) + AMPPNP<br /> | **[[5dbx]] – mChk39 residues 63-403 (mutant) + AMPPNP<br /> | ||
Line 203: | Line 225: | ||
**[[5l2q]] – hChk40 kinase homology domain<br /> | **[[5l2q]] – hChk40 kinase homology domain<br /> | ||
+ | |||
+ | *'''Dclk1''' | ||
+ | |||
+ | **[[6kyq]] – hChk Dclk1 kinase domain<br /> | ||
+ | **[[6kyr]] – hChk Dclk1 kinase domain (mutant)<br /> | ||
+ | **[[5jzj]] – hChk Dclk1 kinase domain + AMPPN <br /> | ||
+ | **[[5jzn]], [[7kx6]], [[7kxw]] – hChk Dclk1 kinase domain + inhibitor <br /> | ||
+ | **[[7f3g]] – hChk Dclk1 kinase domain + drug <br /> | ||
+ | **[[7kx8]] – hChk Dclk1 C-terminal + inhibitor <br /> | ||
*'''Rac-α hChk (AKT1)'''; domains: pleckstrin homology 1-123; kinase 144-480 | *'''Rac-α hChk (AKT1)'''; domains: pleckstrin homology 1-123; kinase 144-480 | ||
**[[1unp]], [[1unr]] – hRac-α hChk pleckstrin homology domain <br /> | **[[1unp]], [[1unr]] – hRac-α hChk pleckstrin homology domain <br /> | ||
- | **[[2uzr]], [[2uzs]] – hRac-α hChk pleckstrin homology domain (mutant) <br /> | + | **[[2uzr]], [[2uzs]], [[7myx]] – hRac-α hChk pleckstrin homology domain (mutant) <br /> |
**[[1h10]], [[1unq]], [[2uvm]] – hRac-α hChk pleckstrin homology domain + inositol tetrakisphosphate<br /> | **[[1h10]], [[1unq]], [[2uvm]] – hRac-α hChk pleckstrin homology domain + inositol tetrakisphosphate<br /> | ||
- | **[[3o96]], [[4ejn]], [[6s9w]], [[6s9x]], [[6hhj]], [[6hhi]], [[6hhh]], [[6hhg]], [[6hhf]] - hRac-α hChk | + | **[[3o96]], [[4ejn]], [[6s9w]], [[6s9x]], [[6hhj]], [[6hhi]], [[6hhh]], [[6hhg]], [[6hhf]] - hRac-α hChk + inhibitor<br /> |
- | **[[5kcv]] - hRac-α hChk (mutant) + inhibitor<br /> | + | **[[5kcv]], [[7nh4]], [[7nh5]] - hRac-α hChk (mutant) + inhibitor<br /> |
**[[4gv1]], [[4ekl]] - hRac-α hChk kinase domain + inhibitor<br /> | **[[4gv1]], [[4ekl]] - hRac-α hChk kinase domain + inhibitor<br /> | ||
**[[3qkm]], [[6ccy]] - hRac-α hChk kinase domain (mutant) + inhibitor<br /> | **[[3qkm]], [[6ccy]] - hRac-α hChk kinase domain (mutant) + inhibitor<br /> | ||
- | ** | + | **[[6buu]] - hRac-α hChk kinase domain + bisubstrate peptide<br /> |
**[[4ekk]] - hRac-α hChk kinase domain (mutant) + GSK3 peptide + AMPPNP<br /> | **[[4ekk]] - hRac-α hChk kinase domain (mutant) + GSK3 peptide + AMPPNP<br /> | ||
**[[6npz]] - hRac-α hChk kinase domain + peptide + inhibitor<br /> | **[[6npz]] - hRac-α hChk kinase domain + peptide + inhibitor<br /> | ||
**[[3ow4]], [[3qkk]], [[3qkl]], [[6buu]] - hRac-α hChk kinase domain (mutant) + peptide + inhibitor<br /> | **[[3ow4]], [[3qkk]], [[3qkl]], [[6buu]] - hRac-α hChk kinase domain (mutant) + peptide + inhibitor<br /> | ||
+ | **[[7apj]] - hRac-α hChk + nanobody<br /> | ||
- | *'''Rac-β hChk''' | + | *'''Rac-β hChk or AKT2''' |
- | **[[1gzk]], [[1gzn]], [[1gzo]], [[1mrv]], [[1mry]] – | + | **[[1gzk]], [[1gzn]], [[1gzo]], [[1mrv]], [[1mry]] – hRac-β hChk kinase domain<br /> |
- | **[[1p6s]] - | + | **[[1p6s]] - hRac-β hChk pleckstrin homology domain - NMR<br /> |
- | **[[1o6k]] - | + | **[[1o6k]] - hRac-β hChk kinase domain + GSK3 peptide + AMPPNP<br /> |
- | **[[2jdo]], [[2jdr]], [[2uw9]], [[2x39]], [[3cqu]], [[3cqw]] - | + | **[[2jdo]], [[2jdr]], [[2uw9]], [[2x39]], [[3cqu]], [[3cqw]] - hRac-β hChk kinase domain + GSK3 peptide + inhibitor<br /> |
**[[3e87]], [[3e88]], [[3e8d]] - Rac-β hChk kinase domain (mutant) + GSK3 peptide + inhibitor<br / | **[[3e87]], [[3e88]], [[3e8d]] - Rac-β hChk kinase domain (mutant) + GSK3 peptide + inhibitor<br / | ||
- | **[[1o6l]] - | + | **[[1o6l]] - hRac-β hChk kinase domain (mutant) + GSK3 peptide + AMPPNP<br /> |
- | **[[3d0e]] - | + | **[[3d0e]], [[8q61]] - hRac-β hChk kinase domain (mutant) + inhibitor<br /> |
- | *'''Rac-γ hChk''' | + | *'''Rac-γ hChk (AKT3)''' |
**[[2x18]] – Rac-γ hChk PH domain<br /> | **[[2x18]] – Rac-γ hChk PH domain<br /> | ||
Line 234: | Line 266: | ||
*'''A-Raf''' | *'''A-Raf''' | ||
- | **[[1wxm]] – hA-Raf RAS-binding domain - NMR<br /> | + | **[[1wxm]] – hA-Raf RAS-binding domain 19-91 - NMR<br /> |
+ | **[[2mse]] – hA-Raf RAS-binding domain + APOA-I + K-ras - NMR<br /> | ||
*'''B-Raf'''; domains - BRS 38-116; Ras-binding 153-237; kinase 445-723 | *'''B-Raf'''; domains - BRS 38-116; Ras-binding 153-237; kinase 445-723 | ||
- | **[[1uwh]], [[3c4c]] – hB-Raf kinase domain + anticancer drug<br /> | + | **[[8dgs]], [[8dgt]] – hB-Raf in Ras/Raf complex – Cryo EM<br /> |
- | **[[1uwj]] – hB-Raf kinase domain (mutant) + anticancer drug<br /> | + | **[[7zr5]] – hB-Raf + Hsp90 + CDC37 + PP5 – Cryo EM<br /> |
- | **[[2fb8]], [[3d4q]], [[3ii5]], [[3psd]], [[3skc]], [[3tv6]], [[4g9c]], [[4ksp]], [[4ksq]], [[3psb]], [[3ppj]], [[3ppk]], [[3prf]], [[3pri]], [[3tv4]], [[4dbn]], [[4e4x]], [[4mbj]], [[4ehe]], [[3q4c]], [[3q96]], [[3e26]], [[4h58]], [[4e26]], [[4fc0]], [[4pp7]], [[6cad]] – hB-Raf kinase domain + pyrazole inhibitor<br /> | + | **[[1uwh]], [[3c4c]], [[6v2u]], [[6xfp]], [[6xlo]], [[8f7o]], [[8f7p]] – hB-Raf kinase domain + anticancer drug<br /> |
- | **[[4jvg]], [[4ehg]], [[4fk3]], [[3idp]], [[4g9r]], [[4wo5]], [[4mnf]], [[4r5y]], [[4rzv]], [[4rzw]], [[4xv1]], [[4xv2]], [[4xv3]], [[4xv9]], [[4yht]], [[5c9c]], [[5hi2]], [[5ita]], [[5jrq]], [[5jsm]], [[5jt2]], [[6nsq]] – hB-Raf kinase domain (mutant) + pyrazole inhibitor<br /> | + | **[[1uwj]], [[6p3d]] – hB-Raf kinase domain (mutant) + anticancer drug<br /> |
- | **[[5csw]], [[5csx]], [[5ct7]], [[5fd2]], [[5hid]], [[5hie]], [[5val]], [[5vam]], [[6b8u]], [[6n0q]], [[6n0p]] - hB-Raf kinase domain + inhibitor<br /> | + | **[[2fb8]], [[3d4q]], [[3ii5]], [[3psd]], [[3skc]], [[3tv6]], [[4g9c]], [[4ksp]], [[4ksq]], [[3psb]], [[3ppj]], [[3ppk]], [[3prf]], [[3pri]], [[3tv4]], [[4dbn]], [[4e4x]], [[4mbj]], [[4ehe]], [[3q4c]], [[3q96]], [[3e26]], [[4h58]], [[4e26]], [[4fc0]], [[4pp7]], [[6cad]], [[7shv]] – hB-Raf kinase domain + pyrazole inhibitor<br /> |
+ | **[[4jvg]], [[4ehg]], [[4fk3]], [[3idp]], [[4g9r]], [[4wo5]], [[4mnf]], [[4r5y]], [[4rzv]], [[4rzw]], [[4xv1]], [[4xv2]], [[4xv3]], [[4xv9]], [[4yht]], [[5c9c]], [[5hi2]], [[5ita]], [[5jrq]], [[5jsm]], [[5jt2]], [[6nsq]], [[6p7d]], [[6uuo]] – hB-Raf kinase domain (mutant) + pyrazole inhibitor<br /> | ||
+ | **[[5csw]], [[5csx]], [[5ct7]], [[5fd2]], [[5hid]], [[5hie]], [[5val]], [[5vam]], [[6b8u]], [[6n0q]], [[6n0p]], [[7k0v]], [[7p3b]], [[7p3v]], [[8c7x]], [[8c7y]] - hB-Raf kinase domain + inhibitor<br /> | ||
+ | **[[6v34]] – hB-Raf kinase domain (mutant) + inhibitor<br /> | ||
**[[4mne]] – hB-Raf kinase domain + MAPKK1<br /> | **[[4mne]] – hB-Raf kinase domain + MAPKK1<br /> | ||
+ | **[[8f7o]] – hB-Raf kinase domain + drug<br /> | ||
+ | **[[7m0u]] – hB-Raf kinase domain + AMPPNP + drug<br /> | ||
**[[6u2h]] – hB-Raf kinase domain + 14-3-3 ζ/δ<br /> | **[[6u2h]] – hB-Raf kinase domain + 14-3-3 ζ/δ<br /> | ||
+ | **[[7mfe]] – hB-Raf + 14-3-3 ζ/δ – Cryo EM<br /> | ||
+ | **[[7mff]] – hB-Raf + 14-3-3 ζ/δ + inhibitor – Cryo EM<br /> | ||
+ | **[[7mfd]] – hB-Raf + 14-3-3 ζ/δ + MEK + inhibitor – Cryo EM<br /> | ||
**[[6pp9]] – hB-Raf kinase domain + MEK1 + ANP<br /> | **[[6pp9]] – hB-Raf kinase domain + MEK1 + ANP<br /> | ||
+ | **[[7m0x]], [[7m0z]] – hB-Raf kinase domain + MEK1 + ANP + inhibitor<br /> | ||
+ | **[[7m0t]], [[7m0u]], [[7m0v]], [[7m0w]], [[7m0y]] – hB-Raf kinase domain + MEK1 + ANP + drug<br /> | ||
**[[6u2g]] – hB-Raf kinase domain + MEK1 + AMPPCP<br /> | **[[6u2g]] – hB-Raf kinase domain + MEK1 + AMPPCP<br /> | ||
**[[5vr3]] – hB-Raf BRS domain <br /> | **[[5vr3]] – hB-Raf BRS domain <br /> | ||
+ | **[[7jhp]] – hB-Raf BRS domain + Hras<br /> | ||
+ | **[[6ntc]], [[6ntd]] – hB-Raf BRS domain (mutant) + Hras<br /> | ||
+ | **[[6xi7]] – hB-Raf 52-188 + Kras<br /> | ||
**[[2l05]], [[5j17]], [[5j2r]] – hB-Raf RAS-binding domain - NMR<br /> | **[[2l05]], [[5j17]], [[5j2r]] – hB-Raf RAS-binding domain - NMR<br /> | ||
**[[3ny5]] – hB-Raf RAS-binding domain <br /> | **[[3ny5]] – hB-Raf RAS-binding domain <br /> | ||
**[[5j18]] – hB-Raf RAS-binding domain + inhibitor - NMR<br /> | **[[5j18]] – hB-Raf RAS-binding domain + inhibitor - NMR<br /> | ||
+ | **[[6pts]], [[6ptw]] – hB-Raf 56-187 + Kras + apolipoprotein + GMPPNP - NMR<br /> | ||
**[[6uan]], [[6q0k]] – hB-Raf + 14-3-3 ζ – Cryo EM<br /> | **[[6uan]], [[6q0k]] – hB-Raf + 14-3-3 ζ – Cryo EM<br /> | ||
**[[6nyb]] – hB-Raf + 14-3-3 ζ + MEK1 – Cryo EM<br /> | **[[6nyb]] – hB-Raf + 14-3-3 ζ + MEK1 – Cryo EM<br /> | ||
Line 269: | Line 316: | ||
**[[4g0n]], [[4g3x]] – hc-Raf RAS-binding domain + GTPase Hras <br /> | **[[4g0n]], [[4g3x]] – hc-Raf RAS-binding domain + GTPase Hras <br /> | ||
**[[3kud]] – hc-Raf RAS-binding domain (mutant) + GTPase Hras <br /> | **[[3kud]] – hc-Raf RAS-binding domain (mutant) + GTPase Hras <br /> | ||
+ | **[[8epw]] – hc-Raf RAS-binding domain + GTPase Kras <br /> | ||
+ | **[[8atr]], [[8ats]], [[8avo]] – hc-Raf RAS-binding domain + 14-3-3 protein sigma <br /> | ||
+ | **[[6xgu]], [[6xgv]], [[6xha]], [[6xhb]] – hc-Raf RBD+CRD domains 52-188 + GTPase Kras + GMPPNP<br /> | ||
+ | **[[7z5r]], [[8gae]] – hc-Raf RBD domain + Hsp84 + Cdc37 + PP5 + ADP + ATP – Cryo EM<br /> | ||
+ | **[[7zr0]] – hc-Raf RBD domain + Hsp84 + Cdc37 + ATP – Cryo EM<br /> | ||
*'''Snf1-related Chk''' | *'''Snf1-related Chk''' | ||
Line 278: | Line 330: | ||
*'''MAPK-interacting Chk''' or Mnk1 Mnk2 | *'''MAPK-interacting Chk''' or Mnk1 Mnk2 | ||
- | **[[2hw6]] – | + | **[[2hw6]] – hMnk 1 catalytic domain<br /> |
- | **[[2hw7]] – | + | **[[2hw7]] – hMnk 1 catalytic domain + staurosporin<br /> |
- | **[[5wvd]] – | + | **[[5wvd]] – hMnk 1 catalytic domain + inhibitor<br /> |
- | **[[2ac3]] – | + | **[[2ac3]] – hMnk 2 catalytic domain<br /> |
- | **[[2ac5]] – | + | **[[2ac5]] – hMnk 2 catalytic domain (mutant)<br /> |
- | **[[6cj5]], [[6cje]], [[6cjh]], [[6cjw]], [[6cjy]], [[6ck3]], [[6ck6]], [[6cki]] – | + | **[[6cj5]], [[6cje]], [[6cjh]], [[6cjw]], [[6cjy]], [[6ck3]], [[6ck6]], [[6cki]] – hMnk 2 catalytic domain (mutant) + inhibitor<br /> |
- | *'''hChk Pak''' or '''Chk N''' or '''PRK1''';Domains - CRIB 74-109; Hr1B 122-199; kinase 605-942 | + | *'''hChk Pak''' or '''Chk N''' or '''PRK1''';Domains - CRIB 74-109; Hr1B 122-199; catalytic 109-426; kinase 605-942 |
**[[1urf]] – hChk Pak-1 Hr1b domain - NMR<br /> | **[[1urf]] – hChk Pak-1 Hr1b domain - NMR<br /> | ||
Line 293: | Line 345: | ||
**[[4otd]] - hChk Pak-1 kinase domain<br /> | **[[4otd]] - hChk Pak-1 kinase domain<br /> | ||
**[[1yhv]], [[1yhw]], [[3q4z]], [[3q52]], [[3q53]] – hChk Pak-1 kinase domain (mutant)<br /> | **[[1yhv]], [[1yhw]], [[3q4z]], [[3q52]], [[3q53]] – hChk Pak-1 kinase domain (mutant)<br /> | ||
- | **[[4o0r]], [[4o0t]], [[4zji]], [[4zjj]], [[4zlo]], [[4zy4]], [[4zy5]], [[4zy7]], [[5ime]], [[5kbq]], [[5kbr]], [[6b16]] – hChk Pak-1 kinase domain + inhibitor<br /> | + | **[[4o0r]], [[4o0t]], [[4zji]], [[4zjj]], [[4zlo]], [[4zy4]], [[4zy5]], [[4zy7]], [[5ime]], [[5kbq]], [[5kbr]], [[6b16]], [[7vto]] – hChk Pak-1 kinase domain + inhibitor<br /> |
**[[4oti]], [[4oth]], [[4otg]] – hChk Pak-1 kinase domain + inhibitor<br /> | **[[4oti]], [[4oth]], [[4otg]] – hChk Pak-1 kinase domain + inhibitor<br /> | ||
**[[4eqc]], [[4p90]], [[5dew]], [[5dey]], [[5dfp]] – hChk Pak-1 kinase domain (mutant) + inhibitor<br /> | **[[4eqc]], [[4p90]], [[5dew]], [[5dey]], [[5dfp]] – hChk Pak-1 kinase domain (mutant) + inhibitor<br /> | ||
Line 304: | Line 356: | ||
**[[2cdz]] – hChk Pak-4 + purine derivative<br /> | **[[2cdz]] – hChk Pak-4 + purine derivative<br /> | ||
**[[2ov2]] – hChk Pak-4 CRIB domain + RAC3<br /> | **[[2ov2]] – hChk Pak-4 CRIB domain + RAC3<br /> | ||
- | **[[2qon]], [[4fif]], [[4fih]], [[4fii]], [[4jdh]], [[4jdi]], [[4jdj]], [[4jdk]] | + | **[[2qon]], [[4fif]], [[4fih]], [[4fii]], [[4jdh]], [[4jdi]], [[4jdj]], [[4jdk]], [[6wlx]], [[6wly]] – hChk Pak-4 kinase domain + peptide<br /> |
- | **[[4app]], [[4o0v]], [[4o0x]], [[4o0y]], [[4njd]], [[4xbu]], [[5bms]], [[5i0b]], [[5vee]], [[5vef]], [[5zjw]], [[5xvg]], [[5xvf]], [[5xva]] – hChk Pak-4 kinase domain + inhibitor<br /> | + | **[[4app]], [[4o0v]], [[4o0x]], [[4o0y]], [[4njd]], [[4xbu]], [[5bms]], [[5i0b]], [[5vee]], [[5vef]], [[5zjw]], [[5xvg]], [[5xvf]], [[5xva]], [[7cmb]], [[7cp3]], [[7cp4]] – hChk Pak-4 kinase domain + inhibitor<br /> |
**[[2x4z]], [[2xh5]] – hChk Pak-4 kinase domain (mutant) + inhibitor<br /> | **[[2x4z]], [[2xh5]] – hChk Pak-4 kinase domain (mutant) + inhibitor<br /> | ||
**[[5upl]], [[5upk]] – hChk Pak-4 kinase domain (mutant) + CDC42<br /> | **[[5upl]], [[5upk]] – hChk Pak-4 kinase domain (mutant) + CDC42<br /> | ||
**[[5ved]] – hChk Pak-4 kinase domain + staurosporine<br /> | **[[5ved]] – hChk Pak-4 kinase domain + staurosporine<br /> | ||
+ | **[[8ahi]] – hChk Pak-4 300-591 + inhibitor<br /> | ||
+ | **[[7s46]], [[7s48]] – hChk Pak-4 catalytic domain + integrin beta-5 peptide<br /> | ||
**[[2c30]] – hChk Pak-6<br /> | **[[2c30]] – hChk Pak-6<br /> | ||
**[[2odb]] – hChk Pak-6 CRIB domain + CDC42<br /> | **[[2odb]] – hChk Pak-6 CRIB domain + CDC42<br /> | ||
Line 333: | Line 387: | ||
**[[1rwi]], [[1rwl]] - MtChk PknD extracellular domain<br /> | **[[1rwi]], [[1rwl]] - MtChk PknD extracellular domain<br /> | ||
**[[2h34]] – MtChk PknE catalytic domain<br /> | **[[2h34]] – MtChk PknE catalytic domain<br /> | ||
+ | **[[7naa]] – MtChk PknF kinase domain + inhibitor<br /> | ||
**[[4y12]] - MtChk PknG + ATP-gS<br /> | **[[4y12]] - MtChk PknG + ATP-gS<br /> | ||
**[[4y0x]] - MtChk PknG + ADP<br /> | **[[4y0x]] - MtChk PknG + ADP<br /> | ||
+ | **[[7q52]] - MtChk PknG + inhibitor<br /> | ||
**[[4esq]] - MtChk PknH extracellular domain<br /> | **[[4esq]] - MtChk PknH extracellular domain<br /> | ||
**[[5m06]], [[5xka]] - MtChk PknI kinase domain <br /> | **[[5m06]], [[5xka]] - MtChk PknI kinase domain <br /> | ||
**[[5m07]], [[5m08]], [[5m09]] - MtChk PknI kinase domain (mutant)<br /> | **[[5m07]], [[5m08]], [[5m09]] - MtChk PknI kinase domain (mutant)<br /> | ||
**[[5xlm]], [[5xll]] - MtChk PknI sensor domain <br /> | **[[5xlm]], [[5xll]] - MtChk PknI sensor domain <br /> | ||
+ | **[[7mxb]], [[7mxj]], [[7mxk]] - Chk PknG kinase domain + AMPPNP - ''Corynebacterium glutamicum''<br /> | ||
*'''hChk Nek''' | *'''hChk Nek''' | ||
Line 345: | Line 402: | ||
**[[4b9d]] - hChk Nek1 kinase domain (mutant) + inhibitor<br /> | **[[4b9d]] - hChk Nek1 kinase domain (mutant) + inhibitor<br /> | ||
**[[2w5h]] – hChk Nek2 kinase domain<br /> | **[[2w5h]] – hChk Nek2 kinase domain<br /> | ||
- | **[[2jav]], [[2wqo]], [[2xk3]], [[2xk4]], [[2xk6]], [[2xk7]], [[2xk8]], [[2xkc]], [[2xkd]], [[2xke]], [[2xkf]], [[2xnm]], [[2xnn]], [[2xno]], [[2xnp]], [[4a4x]], [[4afe]], [[5m51]], [[5m53]], [[5m55]], [[5m57]], [[6sk9]] – hChk Nek2 + inhibitor<br /> | + | **[[2jav]], [[2wqo]], [[2xk3]], [[2xk4]], [[2xk6]], [[2xk7]], [[2xk8]], [[2xkc]], [[2xkd]], [[2xke]], [[2xkf]], [[2xnm]], [[2xnn]], [[2xno]], [[2xnp]], [[4a4x]], [[4afe]], [[5m51]], [[5m53]], [[5m55]], [[5m57]], [[6sgd]], [[6sk9]], [[6sgh]], [[6sgi]], [[6sgk]], [[8sk9]] – hChk Nek2 + inhibitor<br /> |
**[[2w5a]], [[2w5b]] – hChk Nek2 + nucleotide<br /> | **[[2w5a]], [[2w5b]] – hChk Nek2 + nucleotide<br /> | ||
- | **[[2wqm]] – hChk Nek7<br /> | + | **[[6tm5]] - hChk Nek2 in anaphase-promoting complex – Cryo EM<br /> |
+ | **[[2wqm]], [[6s76]] – hChk Nek7<br /> | ||
**[[2wqn]] – hChk Nek7 + ADP<br /> | **[[2wqn]] – hChk Nek7 + ADP<br /> | ||
**[[5de2]] – hChk Nek7 + hChk Nek9<br /> | **[[5de2]] – hChk Nek7 + hChk Nek9<br /> | ||
**[[6s73]], [[2wqo]] – hChk Nek7 + inhibitor<br /> | **[[6s73]], [[2wqo]] – hChk Nek7 + inhibitor<br /> | ||
+ | **[[6npy]] – hChk Nek7 + Nlrp3<br /> | ||
+ | **[[6s75]] – hChk Nek7 + inhibitor<br /> | ||
+ | |||
+ | *'''Chk Rio''' | ||
+ | |||
+ | **[[6fdo]], [[6fdn]], [[6fdm]] – hChk Rio2 <br /> | ||
+ | **[[4otp]] – hChk Rio1 Rio domain + ADP <br /> | ||
+ | **[[6hk6]], [[7vbt]] – hChk Rio2 + inhibitor <br /> | ||
+ | **[[6eml]], [[6fai]], [[6g18]], [[6g51]], [[6rbd]],[[6rbe]], [[6y7c]] – yChk Rio2 in 40S particle – Cryo EM<br /> | ||
+ | **[[1ztf]] – AfChk Rio1 + adenine derivative – ''Archaeoglobus fulgidus''<br /> | ||
+ | **[[1zth]] – AfChk Rio1 + ADP <br /> | ||
+ | **[[1zp9]] – AfChk Rio1 + ATP <br /> | ||
+ | **[[1tqp]], [[1zao]] – AfChk Rio2 + ATP <br /> | ||
+ | **[[1zar]] – AfChk Rio2 + ADP <br /> | ||
+ | **[[4gyg]] – CtChk Rio2 – ''Chaetonium thermophilum''<br /> | ||
+ | **[[4gyi]] – CtChk Rio2 + ADP <br /> | ||
*hChk Vrk (vaccinia-related kinase) | *hChk Vrk (vaccinia-related kinase) | ||
Line 357: | Line 431: | ||
**[[3op5]] – hChk Vrk1 kinase domain (mutant)<br /> | **[[3op5]] – hChk Vrk1 kinase domain (mutant)<br /> | ||
**[[5ukf]] – hChk Vrk1 kinase domain + inhibitor<br /> | **[[5ukf]] – hChk Vrk1 kinase domain + inhibitor<br /> | ||
- | **[[5uvf]], [[6cnx]], [[6bu6]], [[6cfm]], [[6dd4]], [[6bp0]], [[6bru]], [[6btw]], [[6cmm]], [[6cqh]], [[6csw]] – hChk Vrk1 kinase domain (mutant) + inhibitor<br /> | + | **[[5uvf]], [[6cnx]], [[6bu6]], [[6cfm]], [[6dd4]], [[6bp0]], [[6bru]], [[6btw]], [[6cmm]], [[6cqh]], [[6csw]], [[6npn]], [[6vxu]], [[6vzh]] – hChk Vrk1 kinase domain (mutant) + inhibitor<br /> |
**[[6ac9]] – hChk Vrk1 kinase domain (mutant) + AMPPNP<br /> | **[[6ac9]] – hChk Vrk1 kinase domain (mutant) + AMPPNP<br /> | ||
+ | **[[7tan]] – hChk Vrk1 kinase domain + nucleosome – Cryo EM<br /> | ||
**[[2v62]] – hChk Vrk2 kinase domain <br /> | **[[2v62]] – hChk Vrk2 kinase domain <br /> | ||
- | **[[5uu1]], [[6ncg]] – hChk Vrk2 kinase domain + inhibitor<br /> | + | **[[5uu1]], [[6ncg]], [[8q1z]] – hChk Vrk2 kinase domain + inhibitor<br /> |
- | *Chk Wnk (protein kinase lysine-deficient) | + | *Chk Wnk (protein kinase lysine-deficient); Domains - kinase 194-483; CCT1 454-549 |
**[[6cn9]], [[4q2a]], [[4pwn]] - hChk Wnk1 kinase domain (mutant)<br /> | **[[6cn9]], [[4q2a]], [[4pwn]] - hChk Wnk1 kinase domain (mutant)<br /> | ||
Line 368: | Line 443: | ||
**[[5wdy]], [[5we8]] - hChk Wnk1 kinase domain + inhibitor + ANP<br /> | **[[5wdy]], [[5we8]] - hChk Wnk1 kinase domain + inhibitor + ANP<br /> | ||
**[[6elm]] - hChk Wnk2 CCT1 domain <br /> | **[[6elm]] - hChk Wnk2 CCT1 domain <br /> | ||
- | **[[5drb]] - rChk Wnk1 kinase domain (mutant) + inhibitor<br /> | + | **[[5drb]], [[6ol2]] - rChk Wnk1 kinase domain (mutant) + inhibitor<br /> |
- | **[[6fbk]] - hChk Wnk2 CCT1 domain + | + | **[[6fbk]] - hChk Wnk2 CCT1 domain + Wnk1 peptide <br /> |
**[[5o1v]], [[5o21]], [[5o23]] - hChk Wnk3 kinase domain <br /> | **[[5o1v]], [[5o21]], [[5o23]] - hChk Wnk3 kinase domain <br /> | ||
**[[5o2c]] - hChk Wnk3 kinase + CCT1 domains <br /> | **[[5o2c]] - hChk Wnk3 kinase + CCT1 domains <br /> | ||
**[[5o26]], [[5tf9]] - hChk Wnk3 kinase domain + AMPPNP<br /> | **[[5o26]], [[5tf9]] - hChk Wnk3 kinase domain + AMPPNP<br /> | ||
**[[5o2b]] - hChk Wnk3 kinase domain + inhibitor<br /> | **[[5o2b]] - hChk Wnk3 kinase domain + inhibitor<br /> | ||
- | **[[2lru]] – rChk Wnk1 autoinhibitory domain - NMR<br /> | + | **[[8edh]] - hChk Wnk3 kinase domain (mutant) + inhibitor<br /> |
+ | **[[2lru]] – rChk Wnk1 autoinhibitory domain 480-572 - NMR<br /> | ||
**[[5w7t]] - rChk Wnk1 kinase domain <br /> | **[[5w7t]] - rChk Wnk1 kinase domain <br /> | ||
+ | **[[7uos]] - rChk Wnk1 kinase domain (mutant)<br /> | ||
*'''TANK-binding kinase''' | *'''TANK-binding kinase''' | ||
**[[4efo]] – hChk Tbk1 ubiquitin-like domain <br /> | **[[4efo]] – hChk Tbk1 ubiquitin-like domain <br /> | ||
- | **[[6rsr]] – hChk Tbk1 + inhibitor <br /> | + | **[[6rsr]], [[6rsu]] – hChk Tbk1 + inhibitor <br /> |
**[[4im0]], [[4im2]], [[4im3]], [[4iw0]], [[4iwo]], [[4iwp]], [[4ipq]], [[6rst]] – hChk Tbk1 (mutant) + inhibitor <br /> | **[[4im0]], [[4im2]], [[4im3]], [[4iw0]], [[4iwo]], [[4iwp]], [[4ipq]], [[6rst]] – hChk Tbk1 (mutant) + inhibitor <br /> | ||
**[[6cq5]], [[6cq4]], [[6cq0]], [[6boe]], [[6bod]], [[6bny]], [[5w5v]] – hChk Tbk1 + ulcer drug<br /> | **[[6cq5]], [[6cq4]], [[6cq0]], [[6boe]], [[6bod]], [[6bny]], [[5w5v]] – hChk Tbk1 + ulcer drug<br /> | ||
Line 393: | Line 470: | ||
**[[2vuw]], [[2wb8]] – hChk Haspin kinase domain <br /> | **[[2vuw]], [[2wb8]] – hChk Haspin kinase domain <br /> | ||
**[[3dle]] – hChk Haspin kinase domain + AMP<br /> | **[[3dle]] – hChk Haspin kinase domain + AMP<br /> | ||
- | **[[3e7v]], [[3f2n]], [[3fmd]], [[3iq7]], [[4qtc]], [[5htb]], [[5htc]] | + | **[[3e7v]], [[3f2n]], [[3fmd]], [[3iq7]], [[4qtc]], [[5htb]], [[5htc]], [[6z56]], [[6z57]], [[6z58]], [[6z59]], [[6z5a]], [[6z5b]], [[6z5c]]. [[6z5d]], [[6z5e]], [[7avq]], [[7ops]] – hChk Haspin kinase domain + inhibitor<br /> |
+ | **[[7sqm]] – hChk Haspin kinase domain + antimalarial<br /> | ||
**[[6g38]], [[6g34]], [[6g35]], [[6g36]], [[6g37]] – hChk Haspin kinase domain + tubercidin derivative<br /> | **[[6g38]], [[6g34]], [[6g35]], [[6g36]], [[6g37]] – hChk Haspin kinase domain + tubercidin derivative<br /> | ||
**[[6g39]], [[6g3a]] – hChk Haspin kinase domain (mutant) + tubercidin derivative<br /> | **[[6g39]], [[6g3a]] – hChk Haspin kinase domain (mutant) + tubercidin derivative<br /> | ||
Line 407: | Line 485: | ||
**[[2qnj]] – hChk MARK3 catalytic+UBA domains <br /> | **[[2qnj]] – hChk MARK3 catalytic+UBA domains <br /> | ||
**[[3fe3]] – hChk MARK3 catalytic+UBA domains (mutant)<br /> | **[[3fe3]] – hChk MARK3 catalytic+UBA domains (mutant)<br /> | ||
+ | **[[7p1l]] – hChk MARK3 catalytic+UBA domains + inhibitor <br /> | ||
**[[5es1]] – hChk MARK4 catalytic+UBA domains + inhibitor<br /> | **[[5es1]] – hChk MARK4 catalytic+UBA domains + inhibitor<br /> | ||
**[[1zmu]] – rChk MARK2 catalytic+UBA domains <br /> | **[[1zmu]] – rChk MARK2 catalytic+UBA domains <br /> | ||
Line 420: | Line 499: | ||
**[[6f7b]] – hChk Bub1 kinase domain + inhibitor<br /> | **[[6f7b]] – hChk Bub1 kinase domain + inhibitor<br /> | ||
**[[4a1g]] – hChk Bub1 TPR domain + CASC5 KI motif<br /> | **[[4a1g]] – hChk Bub1 TPR domain + CASC5 KI motif<br /> | ||
+ | **[[4ggd]] - hChk Bub1 + cell division cycle protein<br /> | ||
+ | **[[6tlj]], [[5khu]] - hChk Bub1 in anaphase-promoting complex – Cryo EM<br /> | ||
+ | **[[6jkk]] – DmChk Bub1 kinase domain <br /> | ||
+ | **[[6jkm]] – DmChk Bub1 kinase domain + ADP<br /> | ||
**[[5jja]] – hChk Bub1 residues 661-734 + PP2A<br /> | **[[5jja]] – hChk Bub1 residues 661-734 + PP2A<br /> | ||
**[[3esl]] – yChk Bub1 N terminal <br /> | **[[3esl]] – yChk Bub1 N terminal <br /> | ||
Line 440: | Line 523: | ||
**[[1aue]] – hFRAP FRB domain<BR /> | **[[1aue]] – hFRAP FRB domain<BR /> | ||
**[[2gaq]], [[2npu]] – hFRAP FRB domain - NMR<BR /> | **[[2gaq]], [[2npu]] – hFRAP FRB domain - NMR<BR /> | ||
+ | **[[8ppz]] – hFRAP FRB domain + FKBP + pyridine derivative<BR /> | ||
**[[3fap]], [[2fap]], [[4fap]] – hFRAP FRB domain + FKBP + rapamycin analog<BR /> | **[[3fap]], [[2fap]], [[4fap]] – hFRAP FRB domain + FKBP + rapamycin analog<BR /> | ||
**[[4drh]], [[4dri]], [[4drj]], [[5gpg]] – hFRAP FRB domain + FKBP + rapamycin<BR /> | **[[4drh]], [[4dri]], [[4drj]], [[5gpg]] – hFRAP FRB domain + FKBP + rapamycin<BR /> | ||
+ | **[[6m4u]], [[6m4w]] – hChk Mtor FRB domain (mutant) + FKBP1A + rapamycin <br /> | ||
**[[5wbh]] – hFRAP FRB domain + S6K1 peptide <br /> | **[[5wbh]] – hFRAP FRB domain + S6K1 peptide <br /> | ||
- | *''mTOR domain residues 1376-2549'' | + | *''mTOR FAT+PIKK domain residues 1376-2549'' |
**[[4jsn]] – hFRAP + TORC subunit LST8<BR /> | **[[4jsn]] – hFRAP + TORC subunit LST8<BR /> | ||
Line 461: | Line 546: | ||
**[[6sb0]] – hChk Mtor + RAPTOR + LST8 + RAGA + RAGC + proline-rich Akt1 substrate – Cryo EM <br /> | **[[6sb0]] – hChk Mtor + RAPTOR + LST8 + RAGA + RAGC + proline-rich Akt1 substrate – Cryo EM <br /> | ||
**[[5zcs]] – hmTOR + LST8 + AVO3 + TORC2 – Cryo EM <br /> | **[[5zcs]] – hmTOR + LST8 + AVO3 + TORC2 – Cryo EM <br /> | ||
+ | **[[7tzo]] – hTORC2 in mTORC2 complex– Cryo EM <br /> | ||
+ | **[[6zwm]], [[6zwo]], [[7owg]], [[7pe7]], [[7pe8]], [[7pe9]], [[7pea]], [[7peb]], [[7pec]], [[7uxc]], [[8era]] – mTOR in mTor complex – Cryo EM <br /> | ||
*'''Gcn2''' | *'''Gcn2''' | ||
Line 470: | Line 557: | ||
**[[1zyd]] – yChk Gcn2 + ATP<br /> | **[[1zyd]] – yChk Gcn2 + ATP<br /> | ||
**[[4otn]] – mChk Gcn2 C terminal domain <br /> | **[[4otn]] – mChk Gcn2 C terminal domain <br /> | ||
+ | |||
+ | *'''LRRK1''' or leucine-rich repeat Chk1 | ||
+ | |||
+ | **[[8e04]], [[8e05]], [[8e06]], [[8fac]] – hLRRK1 – Cryo EM <br /> | ||
+ | |||
+ | *'''LRRK2''' or leucine-rich repeat Chk2 or dardarin | ||
+ | |||
+ | **[[6xr4]] – hLRRK2 – Cryo EM <br /> | ||
+ | **[[7lht]], [[7lhw]], [[7li4]] – hLRRK2 + ATP + GDP – Cryo EM <br /> | ||
+ | **[[7li3]] – hLRRK2 (mutant) + ATP + GDP – Cryo EM <br /> | ||
+ | **[[6oje]], [[7thy]] – hLRRK2 GTPase domain 1329-1520<br /> | ||
+ | **[[6ojf]] – hLRRK2 GTPase domain (mutant) <br /> | ||
+ | **[[6dlo]], [[6dlp]] – hLRRK2 WD40 domain<br /> | ||
+ | **[[7thz]] – hLRRK2 1330-1527 + GDP <br /> | ||
+ | **[[6vno]], [[6vp6]], [[6vp7]] – hLRRK2 C terminal 1330-2527 – Cryo EM <br /> | ||
+ | **[[6vp8]] – hLRRK2 C terminal 1330-2527 + COR domain 1670-1950 + WD40 domain 2140-2489 – Cryo EM <br /> | ||
+ | **[[6s6q]] – AtLRRK2 ectodomain + protein casparian strip peptide <br /> | ||
*'''Pim''' | *'''Pim''' | ||
- | *Pim1 | + | *Pim1 catalytic domain residues 14-313 |
- | **[[1xqz]], [[1ywv]], [[4jx3]] – hPim1 catalytic domain | + | **[[1xqz]], [[1ywv]], [[4jx3]] – hPim1 catalytic domain <br /> |
**[[1yxs]] – hPim1 catalytic domain (mutant) <br /> | **[[1yxs]] – hPim1 catalytic domain (mutant) <br /> | ||
- | **[[4jx3]] – hPim1 kinase domain <br /> | ||
**[[1xr1]], [[1yxt]] – hPim1 catalytic domain + AMPPNP <br /> | **[[1xr1]], [[1yxt]] – hPim1 catalytic domain + AMPPNP <br /> | ||
**[[1yxu]] – hPim1 catalytic domain + AMP <br /> | **[[1yxu]] – hPim1 catalytic domain + AMP <br /> | ||
- | **[[1yxv]] | + | **[[1yxv]], [[5ipj]] – hPim1 catalytic domain + quinoline derivative <br /> |
- | + | ||
**[[1yxx]] – hPim1 catalytic domain + indole derivative <br /> | **[[1yxx]] – hPim1 catalytic domain + indole derivative <br /> | ||
- | **[[3a99]] – hPim1 kinase domain + phosphoaminophosphonic acid adenylate <br /> | ||
**[[2bzj]], [[2bzh]], [[2bzi]] – hPim1 catalytic domain (mutant) + organometallic ligand <br /> | **[[2bzj]], [[2bzh]], [[2bzi]] – hPim1 catalytic domain (mutant) + organometallic ligand <br /> | ||
+ | **[[2o3p]], [[2o63]], [[2o64]], [[2o65]], [[3c4e]], [[3jxw]], [[3jy0]], [[3jya]], [[3r00]], [[3r01]], [[3r02]], [[3r04]], [[3vbq]], [[3vbt]], [[3vbv]], [[3vbw]], [[3vbx]], [[3vby]], [[3vc4]], [[3umw]], [[3umx]], [[4enx]], [[4eny]], [[4k1b]], [[4k18]], [[4k0y]], [[4iaa]], [[4i41]], [[4ll5]], [[4lm5]], [[4lmu]], [[4mta]], [[6kzi]], [[4mbl]], [[4mbi]], [[4n6y]], [[4n6z]], [[4n70]], [[4xh6]], [[5iis]], [[5kgd]], [[5kge]], [[5kgg]], [[5kgi]], [[5kgk]], [[5kzi]], [[5vua]], [[5vub]], [[5vuc]], [[6mt0]], [[6vrv]], [[7oov]], [[7oow]], [[7oox]], [[7xsv]] – hPim1 catalytic domain + inhibitor <br /> | ||
+ | **[[2j2i]], [[3we8]] – hPim1 catalytic domain (mutant)+ inhibitor <br /> | ||
+ | |||
+ | *Pim1 kinase domain residues 92-404 | ||
+ | |||
+ | **[[4jx3]] – hPim1 kinase domain <br /> | ||
+ | **[[3uix]], [[5c1q]] – hPim1 kinase domain residues 120-404 + quinoline derivative <br /> | ||
+ | **[[3a99]] – hPim1 kinase domain + phosphoaminophosphonic acid adenylate <br /> | ||
**[[2oi4]], [[3bwf]] – hPim1 kinase domain (mutant) + organometallic ligand <br /> | **[[2oi4]], [[3bwf]] – hPim1 kinase domain (mutant) + organometallic ligand <br /> | ||
- | **[[1xws]], [[ | + | **[[1xws]], [[4alu]], [[4alv]], [[4alw]], [[4as0]], [[4bzn]], [[4bzo]], [[4dtk]], [[4jx7]], [[4rbl]], [[4rc2]], [[4rc3]], [[4rc4]], [[4ty1]], [[4wrs]], [[4wsy]], [[4wt6]], [[4xhk]], [[[5dgz]], [5dhj]], [[5dia]], [[5dwr]], [[5eol]], [[5kcx]], [[5o11]], [[5o12]], [[5o13]], [[5tel]], [[5tex]], [[5toe]], [[5v80]], [[5v82]]. [[6bsk]], [[6l11]], [[6l12]], [[6l13]], [[6l14]], [[6l15]], [[6l16]], [[6l17]], [[6no8]], [[6no9]], [[6vru]], [[6ykd]], [[7zun]] – hPim1 kinase domain + inhibitor <br /> |
**[[6ayd]] – hPim1 kinase domain (mutant)+ inhibitor <br /> | **[[6ayd]] – hPim1 kinase domain (mutant)+ inhibitor <br /> | ||
- | **[[2o3p]], [[2o63]], [[2o64]], [[2o65]], [[3jxw]], [[3jy0]], [[3jya]], [[3r00]], [[3r01]], [[3r02]], [[3r04]], [[3vbq]], [[3vbt]], [[3vbv]], [[3vbw]], [[3vbx]], [[3vby]], [[3vc4]], [[3umx]], [[4enx]], [[4eny]], [[3umw]], [[4ll5]], [[4lm5]], [[3c4e]], [[5vuc]], [[5vub]], [[5vua]], [[4n70]], [[4n6z]], [[4n6y]], [[4mta]], [[4med]], [[4mbl]], [[4mbi]], [[4lmu]], [[4k1b]], [[4k18]], [[4k0y]], [[4iaa]], [[4i41]], [[6mt0]] – hPim1 catalytic domain + inhibitor <br /> | ||
- | **[[2j2i]], [[3we8]] – hPim1 catalytic domain (mutant)+ inhibitor <br /> | ||
- | **[[5tur]] - hPim1 + inhibitor <br /> | ||
- | *Pim1 complex with consensus peptide | + | *Pim1 full length |
+ | |||
+ | **[[4rpv]], [[5tur]] - hPim1 + inhibitor <br /> | ||
+ | |||
+ | *Pim1 complex with consensus peptide (pimtide) | ||
**[[2bil]], [[3cxw]], [[3cy2]], [[3cy3]], [[6qxk]], [[6pcw]], [[6pdi]], [[6pdn]], [[6pdo]], [[6pdp]] – hPim1 kinase domain + inhibitor + consensus peptide<br /> | **[[2bil]], [[3cxw]], [[3cy2]], [[3cy3]], [[6qxk]], [[6pcw]], [[6pdi]], [[6pdn]], [[6pdo]], [[6pdp]] – hPim1 kinase domain + inhibitor + consensus peptide<br /> | ||
**[[3jpv]], [[3qf9]] - hPim1 catalytic domain + inhibitor + consensus peptide<br /> | **[[3jpv]], [[3qf9]] - hPim1 catalytic domain + inhibitor + consensus peptide<br /> | ||
**[[2c3i]], [[5ndt]], [[5n5m]], [[5n5l]], [[5n52]], [[5n51]], [[5n50]], [[5n4z]], [[5n4y]], [[5n4x]], [[5n4v]], [[5n4u]], [[5n4r]], [[5n4o]], [[5n4n]], [[5mzl]] – hPim1 kinase domain (mutant) + inhibitor + consensus peptide <br /> | **[[2c3i]], [[5ndt]], [[5n5m]], [[5n5l]], [[5n52]], [[5n51]], [[5n50]], [[5n4z]], [[5n4y]], [[5n4x]], [[5n4v]], [[5n4u]], [[5n4r]], [[5n4o]], [[5n4n]], [[5mzl]] – hPim1 kinase domain (mutant) + inhibitor + consensus peptide <br /> | ||
- | **[[4gw8]] – hPim1 catalytic domain (mutant) + inhibitor + | + | **[[4gw8]], [[7qb2]], [[7qfm]], [[7z6u]], [[8afr]] – hPim1 catalytic domain (mutant) + inhibitor + pimtide<br /> |
**[[2bzk]] – hPim1 kinase domain (mutant)+ AMPPNP + consensus peptide <br /> | **[[2bzk]] – hPim1 kinase domain (mutant)+ AMPPNP + consensus peptide <br /> | ||
**[[3ma3]] – hPim1 catalytic domain + inhibitor + PSer + consensus peptide<br /> | **[[3ma3]] – hPim1 catalytic domain + inhibitor + PSer + consensus peptide<br /> | ||
Line 511: | Line 621: | ||
**[[4x7q]] – hPim2 catalytic domain + inhibitor<br /> | **[[4x7q]] – hPim2 catalytic domain + inhibitor<br /> | ||
+ | **[[2iwi]] – hPim2 catalytic domain + Ru ligand<br /> | ||
- | *'''Rip or receptor-interacting Chk; Domains – catalytic 1-294; Death 561-671''' | + | *'''Rip or receptor-interacting Chk; Domains – catalytic 1-294; Amyloid fibril 418-518; Death 561-671''' |
**[[6ac5]] – hRip1 death domain <br /> | **[[6ac5]] – hRip1 death domain <br /> | ||
- | **[[6r5f]], [[6nw2]], [[6c4d]], [[6c3e]], [[5tx5]] – hRip1 catalytic domain + inhibitor <br /> | + | **[[6r5f]], [[6nw2]], [[6c4d]], [[6c3e]], [[5tx5]], [[7fcz]], [[7fd0]], [[7ydx]] – hRip1 catalytic domain + inhibitor <br /> |
**[[6rln]], [[6ocq]], [[6nyh]], [[6hho]] – hRip1 catalytic domain (mutant) + inhibitor <br /> | **[[6rln]], [[6ocq]], [[6nyh]], [[6hho]] – hRip1 catalytic domain (mutant) + inhibitor <br /> | ||
**[[6ggs]] – hRip2 – Cryo EM <br /> | **[[6ggs]] – hRip2 – Cryo EM <br /> | ||
Line 521: | Line 632: | ||
**[[6szj]], [[6sze]], [[6s1f]], [[6rna]], [[6rn8]], [[6hmx]], [[6fu5]], [[6es0]], [[5w5o]], [[5w5j]] – hRip2 catalytic domain + inhibitor <br /> | **[[6szj]], [[6sze]], [[6s1f]], [[6rna]], [[6rn8]], [[6hmx]], [[6fu5]], [[6es0]], [[5w5o]], [[5w5j]] – hRip2 catalytic domain + inhibitor <br /> | ||
**[[6ul8]] – hRip2 catalytic domain (mutant) + inhibitor <br /> | **[[6ul8]] – hRip2 catalytic domain (mutant) + inhibitor <br /> | ||
+ | **[[8aza]] – hRip2 catalytic domain + XiaP Bir2 domain – Cryo EM <br /> | ||
+ | **[[7mx3]] – hRip3 catalytic domain (mutant) + inhibitor <br /> | ||
+ | **[[7mon]] – hRip3 catalytic domain (mutant) + MLKL <br /> | ||
+ | **[[7dac]] – hRip3 amyloid fibril - NMR <br /> | ||
+ | **[[7da4]] – hRip3 amyloid fibril – Cryo EM<br /> | ||
**[[6oko]] – mRip3 catalytic domain + inhibitor <br /> | **[[6oko]] – mRip3 catalytic domain + inhibitor <br /> | ||
+ | **[[6jpd]] – mRip3 residues 409-486 - NMR <br /> | ||
**[[5wnm]], [[5wnj]] – mRip4 catalytic domain (mutant) + drug <br /> | **[[5wnm]], [[5wnj]] – mRip4 catalytic domain (mutant) + drug <br /> | ||
**[[5wnl]] – mRip4 catalytic domain (mutant) + staurosporine <br /> | **[[5wnl]] – mRip4 catalytic domain (mutant) + staurosporine <br /> | ||
Line 533: | Line 650: | ||
**[[5ci7]], [[6mnh]] – hChk Ulk1 (mutant) + inhibitor<br /> | **[[5ci7]], [[6mnh]] – hChk Ulk1 (mutant) + inhibitor<br /> | ||
**[[4wnp]], [[4wno]] – hChk Ulk1 + IST1 homolog<br /> | **[[4wnp]], [[4wno]] – hChk Ulk1 + IST1 homolog<br /> | ||
- | **[[6qav]], [[6qau]], [[6qat]] – hChk Ulk2 + inhibitor<br /> | + | **[[8soi]], [[8sqz]] – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein<br /> |
+ | **[[8srm]] – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein – Cryo EM<br /> | ||
+ | **[[9c82]] – hChk Ulk1 + RB1-inducible coiled-coil protein + autophagy-related protein + PI3K – Cryo EM<br /> | ||
+ | **[[6qav]], [[6qau]], [[6qat]], [[6yid]] – hChk Ulk2 + inhibitor<br /> | ||
**[[4wzx]] – hChk Ulk3 MIT 2 domain + inhibitor<br /> | **[[4wzx]] – hChk Ulk3 MIT 2 domain + inhibitor<br /> | ||
**[[6fdz]], [[6fdy]] – hChk Ulk3 + leukemia drug<br /> | **[[6fdz]], [[6fdy]] – hChk Ulk3 + leukemia drug<br /> | ||
Line 553: | Line 673: | ||
**[[4pu3]], [[4pu4]] – SoChk Hipa + Hipb + DNA - ''Shewanella oneidensis''<br /> | **[[4pu3]], [[4pu4]] – SoChk Hipa + Hipb + DNA - ''Shewanella oneidensis''<br /> | ||
**[[4pu5]] – SoChk Hipa + AMPPNP<br /> | **[[4pu5]] – SoChk Hipa + AMPPNP<br /> | ||
+ | |||
+ | *'''Chk Smg''' | ||
+ | |||
+ | **[[6l53]] – hChk Smg1 – Cryo EM <br /> | ||
+ | **[[7pw6]] – hChk Smg1 + inhibitor – Cryo EM <br /> | ||
+ | **[[7pw7]] – hChk Smg1 + Smg9 + inhibitor – Cryo EM <br /> | ||
+ | **[[7pw9]] – hChk Smg1 + Smg9 + AMPPNP + ATP – Cryo EM <br /> | ||
+ | **[[6l54]], [[6syt]] – hChk Smg1 + Smg8 + Smg9 – Cryo EM <br /> | ||
+ | **[[7pw4]], [[7pw5]] – hChk Smg1 + Smg8 + Smg9 + inhibitor – Cryo EM <br /> | ||
+ | **[[7pw8]] – hChk Smg1 + Smg8 + Smg9 + AMPPNP – Cryo EM <br /> | ||
+ | **[[6z3r]] – hChk Smg1 + Smg8 + Smg9 + regulator of nonsense transcripts – Cryo EM <br /> | ||
+ | **[[2hwy]] – hChk Smg5 PIN domain <br /> | ||
+ | **[[2hww]], [[2hwx]] – hChk Smg6 PIN domain (mutant)<br /> | ||
+ | **[[4um2]] – hChk Smg6 TPR domain <br /> | ||
+ | **[[1ya0]] – hChk Smg7 N terminal <br /> | ||
+ | |||
+ | *'''Chk Vprbp or DCAF1''' | ||
+ | |||
+ | **[[4pxw]], [[8ood]] – hChk Vprbp WD repeat domain 1039-1401 (mutant) <br /> | ||
+ | **[[7sse]], [[7ufv]], [[8f8e]], [[8og5]], [[8og6]], [[8og7]], [[8og8]], [[8og9]], [[8oga]], [[8ogb]], [[8ogc]], [[8oo5]], [[8ood]] – hChk Vprbp WD repeat domain (mutant) + inhibitor<br /> | ||
+ | **[[5aja]] – hChk Vprbp WD repeat domain + VPX + SAMHD1<br /> | ||
*'''Other Chk''' | *'''Other Chk''' | ||
Line 558: | Line 699: | ||
**[[1wak]] – hChk Sprk1 <br /> | **[[1wak]] – hChk Sprk1 <br /> | ||
**[[3dak]] – hChk Osr1 kinase domain <br /> | **[[3dak]] – hChk Osr1 kinase domain <br /> | ||
+ | **[[7okw]] – hChk Osr1 C-terminal <br /> | ||
**[[4aw2]] – hChk Mrckα kinase domain<br /> | **[[4aw2]] – hChk Mrckα kinase domain<br /> | ||
- | **[[4pxw]] – hChk Vprbp WD repeat domain (mutant)<br /> | + | **[[4pxw]], [[8ood]] – hChk Vprbp WD repeat domain (mutant)<br /> |
+ | **[[7v7c]] – hChk Vprbp in DDB1-VPRBP-VPR-UNG2 complex – Cryo EM<br /> | ||
+ | **[[7v7c]] – hChk Vprbp in DDB1-VPRBP-VPR-UNG2 complex – Cryo EM<br /> | ||
**[[1uf0]] – hChk Dcamkl1 DCX domain – NMR<br /> | **[[1uf0]] – hChk Dcamkl1 DCX domain – NMR<br /> | ||
- | + | **[[1u5q]] – rChk Tao2 kinase domain <br /> | |
- | **[[1u5q | + | |
**[[2cos]] – mChk Lats2 – NMR<br /> | **[[2cos]] – mChk Lats2 – NMR<br /> | ||
**[[1xte]], [[1xtn]], [[6edx]] – mChk Sgk3 PX domain <br /> | **[[1xte]], [[1xtn]], [[6edx]] – mChk Sgk3 PX domain <br /> | ||
- | **[[4yom]] – mChk | + | **[[4yom]] – mChk Brsk2 <br /> |
- | **[[4ynz]] – mChk | + | **[[4ynz]] – mChk Brsk1 N terminal domain <br /> |
- | **[[5iri]] – mChk | + | **[[5iri]] – mChk Brsk1 residues 592-719<br /> |
- | **[[5oat]] – rfbChk | + | **[[5oat]], [[7mp8]] – rfbChk Pink1– red flour beetle <br /> |
+ | **[[7t3x]] – Chk Pink1 (mutant) – louse<br /> | ||
**[[4f0g]] – smChk Roco4 kinase domain – slime mold<br /> | **[[4f0g]] – smChk Roco4 kinase domain – slime mold<br /> | ||
+ | **[[5tos]] – AtChk Bik1 <br /> | ||
**[[1q8z]], [[1zyc]] – yChk <br /> | **[[1q8z]], [[1zyc]] – yChk <br /> | ||
**[[1how]], [[1zxe]], [[1zy4]] – yChk (mutant)<br /> | **[[1how]], [[1zxe]], [[1zy4]] – yChk (mutant)<br /> | ||
Line 580: | Line 725: | ||
**[[6u69]] – CaChk Yck2 – ''Candida albicans''<br /> | **[[6u69]] – CaChk Yck2 – ''Candida albicans''<br /> | ||
**[[6sl1]], [[6sl0]], [[6skz]], [[6sky]] – Chk Tel1 – ''Chaetonium thermophilum'' – Cryo EM<br /> | **[[6sl1]], [[6sl0]], [[6skz]], [[6sky]] – Chk Tel1 – ''Chaetonium thermophilum'' – Cryo EM<br /> | ||
- | **[[6ra0]] – | + | **[[6ra0]] – CeChk Dkf1 – ''Chaenorhabditis elegans''<br /><br /> |
- | **[[ | + | **[[7z6e]] – CeChk Mrck1 regulatory domain<br /> |
+ | **[[6tlb]] – Chk – ''Plasmodium falciparum''<br /> | ||
*Other Chk complexes | *Other Chk complexes | ||
- | **[[1wbp]] – hChk Sprk1 + peptide<br /> | + | **[[1wbp]], [[7dd1]] – hChk Sprk1 + peptide<br /> |
**[[3beg]] – hChk Srpk1 + splicing factor SF2<br /> | **[[3beg]] – hChk Srpk1 + splicing factor SF2<br /> | ||
- | **[[3hdm]], [[3hdn]] – hChk Sgk1 (mutant) + inhibitor <br /> | + | **[[3hdm]], [[3hdn]], [[7pue]] – hChk Sgk1 (mutant) + inhibitor <br /> |
**[[2r5t]] – hChk Sgk3 + AMPPNP <br /> | **[[2r5t]] – hChk Sgk3 + AMPPNP <br /> | ||
- | **[[4yff]], [[4yfi]], [[6b5j]] | + | **[[4yff]], [[4yfi]], [[6b5j]], [[7mgj]], [[7mgk]] – hChk Tnni3k + inhibitor <br /> |
- | + | ||
- | + | ||
**[[2v3s]] – hChk Osr1 + hChk Wnk4 peptide <br /> | **[[2v3s]] – hChk Osr1 + hChk Wnk4 peptide <br /> | ||
**[[2vwi]] – hChk Osr1 kinase domain + ANP <br /> | **[[2vwi]] – hChk Osr1 kinase domain + ANP <br /> | ||
- | **[[ | + | **[[7que]], [[7quf]] – hChk Drak1 kinase domain + inhibitor<br /> |
- | + | ||
**[[4crs]] – hChk N2 kinase domain + ATPγS<br /> | **[[4crs]] – hChk N2 kinase domain + ATPγS<br /> | ||
**[[3tku]], [[4ual]], [[3qfv]], [[5ote]], [[5otf]] – hChk Mrckβ + inhibitor<br /> | **[[3tku]], [[4ual]], [[3qfv]], [[5ote]], [[5otf]] – hChk Mrckβ + inhibitor<br /> | ||
Line 610: | Line 753: | ||
**[[5yh3]] – hChk Fam20C 141-578 + pseudokinase Fam20A<br /> | **[[5yh3]] – hChk Fam20C 141-578 + pseudokinase Fam20A<br /> | ||
**[[2gcd]] – rChk Tao2 kinase domain + staurosporine<br /> | **[[2gcd]] – rChk Tao2 kinase domain + staurosporine<br /> | ||
- | **[[5yj9]] – rfbChk Pink1 kinase domain + AMPPNP<br /> | + | **[[1u5r]] – rChk Tao2 kinase domain + ATP<br /> |
+ | **[[5yj9]], [[7mp9]] – rfbChk Pink1 kinase domain + AMPPNP<br /> | ||
+ | **[[6bn1]] – DmChk Hippo SARAH domain + Shar-Pei<br /> | ||
**[[3hgk]] – Chk Pto + effector protein AVRPTOB – Currant tomato<br /> | **[[3hgk]] – Chk Pto + effector protein AVRPTOB – Currant tomato<br /> | ||
+ | **[[3p86]], [[3ppz]] - AtChk Ctr1 + staurosporine<br /> | ||
**[[4f0f]] – smChk Roco4 kinase domain + APPCP <br /> | **[[4f0f]] – smChk Roco4 kinase domain + APPCP <br /> | ||
**[[4f1m]], [[4f1o]] – smChk Roco4 kinase domain (mutant) + APPCP <br /> | **[[4f1m]], [[4f1o]] – smChk Roco4 kinase domain (mutant) + APPCP <br /> | ||
- | **[[4f1t]] – smChk Roco4 kinase domain + inhibitor <br /> | + | **[[4f1t]], [[4yzm]], [[4yzn]] – smChk Roco4 kinase domain + inhibitor <br /> |
**[[5fvm]] - Tor2 + LST8 - ''Kluyveromyces marxianus''<br /> | **[[5fvm]] - Tor2 + LST8 - ''Kluyveromyces marxianus''<br /> | ||
**[[5kc2]] - yVps15 + Vps34 - Cryo EM<br /> | **[[5kc2]] - yVps15 + Vps34 - Cryo EM<br /> | ||
Line 623: | Line 769: | ||
**[[4lqs]], [[4lqq]], [[4lqp]] – yChk Cbk1 residues 251-756 + Cbk1 activator Mob2<br /> | **[[4lqs]], [[4lqq]], [[4lqp]] – yChk Cbk1 residues 251-756 + Cbk1 activator Mob2<br /> | ||
**[[6emk]] – yChk Tor2 + LST8 + TSC11 + AVO1 + AVO2 – Cryo EM<br /> | **[[6emk]] – yChk Tor2 + LST8 + TSC11 + AVO1 + AVO2 – Cryo EM<br /> | ||
- | **[[6s8f]] – yChk Tel1 + | + | **[[6s8f]] – yChk Tel1 + AMPPNP – Cryo EM<br /> |
**[[5yyz]] – yChk Mek1 FHA domain + Hop1<br /> | **[[5yyz]] – yChk Mek1 FHA domain + Hop1<br /> | ||
- | **[[5x6o]] – yChk Mec1 + LCD1 – Cryo EM<br /> | + | **[[5x6o]], [[6z3a]], [[7wzr]], [[7wzw]] – yChk Mec1 + LCD1 – Cryo EM<br /> |
- | **[[ | + | **[[6z2w]], [[6z2x]] – yChk Mec1 (mutant) + LCD1 – Cryo EM<br /> |
- | **[[ | + | **[[7kue]] – yChk Kin28 in TFIIK complex – Cryo EM<br /> |
**[[6u6a]] – CaChk Yck2 + inhibitor<br /> | **[[6u6a]] – CaChk Yck2 + inhibitor<br /> | ||
- | **[[5fvm]] – Chk Tor2 + LST8 – ''Kluyveromyces maximanus''<br | + | **[[5fvm]] – Chk Tor2 + LST8 – ''Kluyveromyces maximanus''<br |
*Serine/threonine protein kinase Rad53 see [[Rad53]] | *Serine/threonine protein kinase Rad53 see [[Rad53]] | ||
+ | |||
+ | *Serine/threonine protein kinase Gsk3B see [[Glycogen synthase kinase 3]] | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Current revision
3D structures of serine/threonine protein kinase
Updated on 23-July-2024